| 553 - 561 |
Metabololipidomic profiling of functional immunoresolvent clusters and eicosanoids in mammalian tissues
Norris PC, Serhan CN |
| 562 - 568 |
Profiling of bioactive lipids in different dendritic cell subsets using an improved multiplex quantitative LC-MS/MS method
Ohba M, Saeki K, Koga T, Okuno T, Kobayashi Y, Yokomizo T |
| 569 - 575 |
Lipidomics biomarker studies: Errors, limitations, and the future
Wood PL, Cebak JE |
| 576 - 581 |
Applications of mass spectrometry-based targeted and non-targeted lipidomics
Lee HC, Yokomizo T |
| 582 - 589 |
Lipid metabolism and lipophagy in cancer
Maan M, Peters JM, Dutta M, Patterson AD |
| 590 - 595 |
Lipidomic insight into cardiovascular diseases
Kohno S, Keenan AL, Ntambi JM, Miyazaki M |
| 596 - 601 |
Sphingolipidomics analysis of large clinical cohorts. Part 1: Technical notes and practical considerations
Chew WS, Seow WL, Chong JR, Lai MKP, Torta F, Wenk MR, Herr DR |
| 602 - 607 |
Sphingolipidomics analysis of large clinical cohorts. Part 2: Potential impact and applications
Chong JR, Xiang P, Wang W, Hind T, Chew WS, Ong WY, Lai MKP, Herr DR |
| 608 - 616 |
Non-alcoholic fatty liver disease: Insights from sphingolipidomics
Montefusco DJ, Allegood JC, Spiegel S, Cowart LA |
| 617 - 622 |
An update on oxysterol biochemistry: New discoveries in lipidomics
Griffiths WJ, Wang YQ |
| 623 - 628 |
The brain lipidome in neurodegenerative lysosomal storage disorders
Fuller M, Futerman AH |
| III - III |
Editorial for BBRC lipidomics special issue
Spiegel S, Ntambi J |
